Table I.
Group | Complete ablation rate (%) | Recurrence rate (%) | Distant recurrence rate (%) |
---|---|---|---|
HCC | 32/34 (94.1) | 5/34 (14.7) | 4/34 (11.8) |
MLC | 21/22 (95.4) | 2/22 (9.1) | 8/22 (36.4) |
P-value | 1.000 | 0.836 | 0.063 |
HCC, hepatocellular carcinoma; MLC, metastatic liver cancer; RFA, radiofrequency ablation.